These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22297581)

  • 21. LADA prevalence estimation and insulin dependency during follow-up.
    Park Y; Hong S; Park L; Woo J; Baik S; Nam M; Lee K; Kim Y;
    Diabetes Metab Res Rev; 2011 Nov; 27(8):975-9. PubMed ID: 22069296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
    Li X; Yang L; Zhou Z; Huang G; Yan X
    Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients.
    Liu J; Bian L; Ji L; Chen Y; Chen H; Gu Y; Ma B; Gu W; Xu X; Shi Y; Wang J; Zhu D; Sun Z; Ma J; Jin H; Shi X; Miao H; Xin B; Zhu Y; Zhang Z; Bu R; Xu L; Shi G; Tang W; Li W; Zhou D; Liang J; Cheng X; Shi B; Dong J; Hu J; Fang C; Zhong S; Yu W; Lu W; Wu C; Qian L; Yu J; Gao J; Fei X; Zhang Q; Wang X; Cui S; Cheng J; Xu N; Wang G; Han G; Xu C; Xie Y; An M; Zhang W; Wang Z; Cai Y; Fu Q; Fu Y; Zheng S; Yang F; Hu Q; Dai H; Jin Y; Zhang Z; Xu K; Li Y; Shen J; Zhou H; He W; Zheng X; Han X; Yu L; She J; Zhang M; Yang T
    Sci China Life Sci; 2016 Sep; 59(9):930-9. PubMed ID: 27225179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes.
    Bansal N; Hampe CS; Rodriguez L; O'Brian Smith E; Kushner J; Balasubramanyam A; Redondo MJ
    Diabet Med; 2017 May; 34(5):641-646. PubMed ID: 26802570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes.
    Hillman M; Törn C; Thorgeirsson H; Landin-Olsson M
    Diabetologia; 2004 Nov; 47(11):1984-9. PubMed ID: 15565370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea.
    Roh MO; Jung CH; Kim BY; Mok JO; Kim CH
    Acta Diabetol; 2013 Apr; 50(2):129-34. PubMed ID: 20953640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.
    Hillman M; Törn C; Landin-Olsson M;
    Clin Exp Immunol; 2009 Aug; 157(2):255-60. PubMed ID: 19604265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Trøndelag Health Study.
    Pettersen E; Skorpen F; Kvaløy K; Midthjell K; Grill V
    Diabetes; 2010 Jan; 59(1):302-10. PubMed ID: 19833889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression.
    Hosszúfalusi N; Vatay A; Rajczy K; Prohászka Z; Pozsonyi E; Horváth L; Grosz A; Gerõ L; Madácsy L; Romics L; Karádi I; Füst G; Pánczél P
    Diabetes Care; 2003 Feb; 26(2):452-7. PubMed ID: 12547879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.
    Bosi E; Boulware DC; Becker DJ; Buckner JH; Geyer S; Gottlieb PA; Henderson C; Kinderman A; Sosenko JM; Steck AK; Bingley PJ;
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2881-2886. PubMed ID: 28531305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metabolic syndrome and latent autoimmune diabetes in adults].
    Li X; Zhou ZG; Yang L; Huang G; Yan X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):676-9. PubMed ID: 14714310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
    Lohmann T; Kellner K; Verlohren HJ; Krug J; Steindorf J; Scherbaum WA; Seissler J
    Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
    Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
    Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).
    Zampetti S; Capizzi M; Spoletini M; Campagna G; Leto G; Cipolloni L; Tiberti C; Bosi E; Falorni A; Buzzetti R;
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3759-65. PubMed ID: 22865904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies against ZnT8 are rare in Central-European LADA patients and absent in MODY patients, including those positive for other autoantibodies.
    Heneberg P; Šimčíková D; Čecháková M; Rypáčková B; Kučera P; Anděl M
    J Diabetes Complications; 2019 Jan; 33(1):46-52. PubMed ID: 30377089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
    Liu L; Li X; Xiang Y; Huang G; Lin J; Yang L; Zhao Y; Yang Z; Hou C; Li Y; Liu J; Zhu D; Leslie RD; Wang X; Zhou Z;
    Diabetes Care; 2015 Jan; 38(1):16-21. PubMed ID: 25336751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.
    Asanghanwa M; Gorus FK; Weets I; der Auwera BV; Aminkeng F; Mbunwe E; Goubert P; Verhaeghen K; Sobngwi E; Wenzlau JM; Hutton JC; Pipeleers DG; Keymeulen B; Mbanya JC; van Schravendijk C
    Diabetes Res Clin Pract; 2014 Jan; 103(1):97-105. PubMed ID: 24332797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
    Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
    Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility.
    Siljander H; Härkönen T; Hermann R; Simell S; Hekkala A; Salonsaari RT; Simell T; Simell O; Ilonen J; Veijola R; Knip M
    Diabetes Metab Res Rev; 2009 Oct; 25(7):615-22. PubMed ID: 19637309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.